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Abstract
Hypoxia in adipose tissue is suggested to be involved in the development of a chronic mild inflammation, which in obesity
can further lead to insulin resistance. The effect of hypoxia on gene expression in adipocytes appears to play a central role in
this inflammatory response observed in obesity. However, the global impact of hypoxia on transcriptional changes in
human adipocytes is unclear. Therefore, we compared gene expression profiles of human Simpson-Golabi-Behmel
syndrome (SGBS) adipocytes under normoxic or hypoxic conditions to detect hypoxia-responsive genes in adipocytes by
using whole human genome microarrays. Microarray analysis showed more than 500 significantly differentially regulated
mRNAs after incubation of the cells under low oxygen levels. To gain further insight into the biological processes, hypoxia-
regulated genes after 16 hours of hypoxia were classified according to their function. We identified an enrichment of genes
involved in important biological processes such as glycolysis, response to hypoxia, regulation of cellular component
movement, response to nutrient levels, regulation of cell migration, and transcription regulator activity. Real-time PCR
confirmed eight genes to be consistently upregulated in response to 3, 6 and 16 hours of hypoxia. For adipocytes the
hypoxia-induced regulation of these genes is shown here for the first time. Moreover in six of these eight genes we
identified HIF response elements in the proximal promoters, specific for the HIF transcription factor family members HIF1A
and HIF2A. In the present study, we demonstrated that hypoxia has an extensive effect on gene expression of SGBS
adipocytes. In addition, the identified hypoxia-regulated genes are likely involved in the regulation of obesity, the incidence
of type 2 diabetes, and the metabolic syndrome.
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Introduction
White adipose tissue is a major endocrine organ and secretes
various bioactive proteins – the adipokines – which are involved in
different physiological processes [1–3]. In obesity, adipose tissue
hypoxia was suggested to be involved in the dysregulation of
adipokine expression and in the consequential development of
obesity-related insulin resistance and chronic inflammation [4,5].
This hypothesis was recently confirmed when evidence was
provided that hypoxia occurs in the adipose tissue of different
obese mouse models and that hypoxia contributes to the endocrine
dysregulations [6–8]. Specifically, transgenic expression of a
constitutively active form of hypoxia-inducible factor 1a (HIF1A)
induced inflammation in the adipose tissue of mice, which further
led to an impaired glucose tolerance [9]. In human subjects
reduced adipose tissue oxygen levels were found to strongly
correlate with percent body fat [10].
Adipose tissue has been shown to be poorly vascularised per se
[5]. In obesity, adipose tissue undergoes expansion and therefore
growth and remodelling of its capillary network is required [11].
Angiogenesis is important to counteract hypoxia within expanding
adipose tissue when clusters become distant form vasculature [11].
Under low oxygen levels the cells respond with an alteration in
gene expression of genes which encode for proteins involved in
angiogenesis, cell proliferation, apoptosis, and glucose and energy
metabolism [12]. Some adipokines like angiopoietin-like 4
(ANGPTL4) and leptin have been implicated in angiogenesis
[13–15]. Furthermore, expression of the hypoxia-sensitive tran-
scription factor HIF1, which mediates angiogenesis and apoptosis
control [16,17], is higher in adipose tissue of obese than in lean
individuals [18] and a reduced expression is associated with type II
diabetes [19,20].
Thus, the impact of hypoxia on gene expression in adipocytes
seems to be central in the inflammatory response observed in
obesity. However, the overall extent of transcriptional changes is
unclear. In the current study whole-genome expression micro-
arrays were used to investigate the regulation of gene expression
by hypoxia in differentiated Simpson-Golabi-Behmel syndrome
(SGBS) cells. As human adipose tissue material with potential to
differentiate is limited, SGBS adipocytes are an excellent model to
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fraction of subcutaneous adipose tissue of a patient suffering from
Simpson-Golabi-Behmel syndrome, these human preadipocytes
feature a long lasting and high capacity for adipose differentiation
and at the same time display a gene expression pattern similar to
mature fat cells [21,22]. Although SGBS cells are a valuable and
well established tool for gene expression in human fat cells [23–
28], gene expression profiling of cultured SGBS adipocytes under
hypoxic conditions has not been investigated yet.
Materials and Methods
Cell culture and reagents
Human SGBS preadipocytes were cultivated as described
previously [21]. Briefly, cells were maintained in DMEM/Ham’s
F12 (1:1) medium (Invitrogen, Paisley, UK) containing 10% fetal
calf serum (FCS; Invitrogen), 100 U/ml penicillin (Invitrogen),
100 mg/ml streptomycin (Invitrogen), 33 mM biotin and 17 mM
pantothenate. To differentiate SGBS cells into adipocytes, near
confluent cells were washed three times with PBS and cultured in
FCS-free differentiation medium: DMEM/Ham’s F12 (1:1)
medium supplemented with 100 U/ml penicillin, 100 mg/ml
streptomycin, 33 mM biotin, 17 mM pantothenate, 10 mg/ml
human transferrin, 10 nM insulin, 100 nM hydrocortisone,
0.2 nM triiodothyronine, 25 nM dexamethasone, 500 mM3 -
isobutyl-1-methylxanthine (IBMX) and 2 mM rosiglitazone (Cay-
man Chemical, Ann Arbor, MI, USA). After 4 days, this medium
was replaced with differentiation medium excluding dexametha-
sone, IBMX and rosiglitazone, which was changed every 3–4 days.
At day 15 after induction of differentiation, fully differentiated
SGBS cells were exposed to hypoxia. To create a hypoxic
environment (1% O2), cells were placed in a MIC-101 modular
incubator chamber (Billups-Rothenberg, Inc., Del Mar, CA,
USA), flushed with a mixture of 1% O2,5 %C O 2 and 94% N2,
sealed and incubated at 37uC. Adipocytes were cultured in the
hypoxic environment for 3, 6 and 16 hours and the control group
was cultured under normoxic conditions (21% O2). Cells were
harvested after treatment for different time periods. Reagents were
obtained from Sigma-Aldrich (St. Louis, MO, USA) unless
specified otherwise.
Microarray analysis
Total RNA was prepared from control and treated SGBS cells,
in triplicate experiments, with the ‘RNeasy Lipid Tissue’ kit
according to the manufacturer’s instructions (Qiagen, Hilden,
Germany), followed by purification of the RNA with the ‘RNeasy
Mini’ kit (Qiagen). RNA quantity and purity was determined by
optical density measurements (OD260/280) and RNA integrity by
using the 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA,
USA). Only high quality RNA was further processed. Gene
expression profiling analysis was performed by the Expression
Profiling Unit at the Medical University Innsbruck according to
the following protocol: 500 ng total RNA was processed to
generate a biotinylated hybridization target using ‘One Cycle
cDNA Synthesis’ kit and the ‘One Cycle Target Labelling’ kit
(Affymetrix, Santa Clara, CA, USA). All procedures were
performed according to the manufacturer’s protocols. In brief,
total RNA was reverse-transcribed into cDNA using an anchored
oligo-dTT7-Primer, converted into double-stranded cDNA and
purified with the ‘Affymetrix Sample Clean-up’ kit according to
the manufacturer’s protocol. Thereafter, cRNA was generated by
T7 polymerase-mediated in vitro transcription including a modified
nucleotide for subsequent biotinylation. Following RNA purifica-
tion, 20 mg of cRNA were fragmented at 95uC using the
Affymetrix fragmentation buffer, mixed with hybridization buffer
containing hybridization controls and hybridized to the ‘Human
Genome U133 2.0’ arrays (Affymetrix). The arrays were stained
and washed in an Affymetrix fluidic station 450. Fluorescence
signals were recorded by an Affymetrix scanner 3000 and image
analysis was performed with the GCOS software.
Real-time PCR analyses
RNA (1 mg) was reverse transcribed using the SuperScript III
First-Strand Synthesis Kit (Invitrogen). Expression levels of genes,
which were consistently differentially expressed in response to all
applied time periods of hypoxia, were assessed by real-time PCR
using the SYBRH Green PCR Master Mix (Applied Biosystems,
Foster City, CA, USA) and fluorescence was detected with the
LightCyclerH 480 System (Roche Diagnostics GmbH, Mannheim,
Germany).
The primers were designed using Gene Runner software
(Hastings Software, Inc.; version 3.05) and synthesized by Micro-
synth (Balgach, Switzerland); following sequences for the primers
were used: ADM: fwd 59-TGATGTACCTGGGTTCGCTC-39
and rev 59-CATCCGCAGTTCCCTCTTC-39, ANKRD37: fwd
59-AGAAGCTCCACTACACAAGGCA-39 and rev 59-AAATC-
CACATGACCAAGCGAG-39, DDIT4: fwd 59-TTGTCTTAG-
CAGTTCTCGCTGA-39andrev59-AAAGGCTAGGCATGGT-
GAGG-39, KDM3A: fwd 59-ATGCTGCAAAGGACACGG-39
and rev 59-GAACTCCATACTCTTGATGAAGACG-39, PFKFB4:
fwd 59-GGAAATGACCTACGAGGAAATTC-39 and rev 59-CC-
AGCACATTCTCTTGCCTC-39, PPP1R3C: fwd 59-CCGCCT-
CTCTGCCTAATGA-39 and rev 59-CCCAGGAAACTCTTCA-
CAGGT-39,V E G F A :f w d5 9-GCGCAAGAAATCCCGGTATA-39
and rev 59-CGCGAGTCTGTGTTTTTGCA-39, WDR73: fwd 59-
GAGTCCTTGAATGGATTGATGAC-39 and rev 59-TGAAATC-
TCTTTCTGGGAATAAGC-39, ZNF395: fwd 59-CCTTTCCTG-
CTGGACGAA-39 and rev 59-TTTGATGCCCACAATGGA-39,
and TBP: fwd 59-GGGAGCTGTGATGTGAAGTTT-39 and rev
59-AAGGAGAACAATTCTGGGTTTG-39. A thermal profile of an
initial 10 min melting step at 95uC, followed by 40 cycles of 15 s at
95uCa n d1m i na t6 0 uC was used. A melting curve profile was
processed after each run to confirm specific transcripts. All reactions
were performed in triplicates and the samples were normalized to the
endogenous reference TBP values. The results are expressed as fold
changes of cycle threshold value relative to controls using the 2
-DDCt
method.
Statistical analyses
Microarray data analysis was performed in R (http://www.r-
project.org) using packages from the Bioconductor project [29].
Functions from the affyPLM package were used for quality
assessments of the microarrays and only good quality arrays were
further analyzed. GeneChip raw expression values were normal-
ized and summarized using the GC robust multi-array average
(GCRMA) method [30]. Enrichment analysis for the Gene
Ontology (GO) categories were computed via the gene ontology
tree machine (www.geneontology.org) and the multiple test
adjustment proposed by Benjamini and Hochberg [31]. The
adjusted p value indicates the significance of enrichment. Further
in silico analyses were conducted using the gene ontology software
package ExPlain 3.0
TM with the integrated Match
TM tool and the
linked TRANSFACProH and BioKnowledge Library (BKL) as
well as predefined gene sets and position weight matrix (PWM)
profiles provided by BIOBASE (www.biobase-international.com).
To identify binding sites in a query set of differentially regulated
genes (Yes-set), we used a background gene set (No-set) and a
predefined PWM profile consisting of 656 PWMs for human
Hypoxia-Induced Gene Regulation in Adipocytes
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No ratio .1 were considered overrepresented in the query set.
Real-time PCR data analyses were performed using the statistical
software package SPSS 11.0 for Windows, SPSS Inc. Chicago, IL,
USA. The results are expressed as mean values 6 SEM. Statistical
differences between groups were analyzed using unpaired two-
tailed Student’s t tests.
Results
Microarray analysis showed 10 significantly differentially
regulated mRNAs after 3 hours, 52 after 6 hours and 514 after
16 hours incubation of the cells under low oxygen levels compared
to the untreated control, which met a fold-change of .2 and a p
value of ,0.05.
To gain insight into the biological processes and molecular
functions of the hypoxia-regulated genes we considered the 514
genes regulated after 16 hours of hypoxia for statistical analysis
with the gene ontology tree machine to classify the regulated genes
according to their function. The analyzed genes are involved in
several biological processes, and significance of enrichment was
evaluated for glycolysis (10 genes), response to hypoxia (16 genes),
regulation of cellular component movement (17 genes), response to
nutrient levels (16 genes), regulation of cell migration (13 genes)
and transcription regulator activity (60 genes). Twenty-four out of
the 514 regulated genes distributed by gene ontology (GO)
classification are involved in more than one pathway (table 1).
Further analysis of the results obtained from the microarrays
showed that 9 mRNAs were consistently differentially expressed at
3, 6 and 16 hours of 1% O2 (figure 1). These genes encode for
adreno-medullin (ADM), ankyrin repeat domain 37 (ANKRD37),
DNA-damage-inducible transcript 4 (DDIT4), lysine(K)-specific
demethylase 3A (KDM3A), 6-phosphofructo-2-kinase/fructose-
2,6-bip-hosphatase 4 (PFKFB4), protein phosphatase 1 regulatory
(inhibitor) subunit 3C (PPP1R3C), vascular endothelial growth
factor A (VEGFA), WD-repeat domain 73 (WDR73), and zink
finger protein 395 (ZNF395). The transcriptional induction values
of these genes obtained from the microarray data are shown in
figure 2. Thereupon we analyzed proximal promoter sequences
(-700 bp to +300 bp with respect to the transcription start site) of
the corresponding genes, looking for transcription factor binding
sites. Applying the F-Match tool integrated in the ExPlain software
we used a predefined set of 561 human housekeeping genes, from
which the set of 514 upregulated genes after 16h were excluded, as
background and the PWM profile mentioned above for the
calculation. The result was filtered according to their p-values
(,0.007) and Yes/No ratio (.1.3) and ranked according to their
Yes/No ratio which represents their abundance in the set of 9
genes (ADM, ANKRD37, DDIT4, KDM3A, PFKFB4,
PPP1R3C, VEGFA, WDR73 and ZNF395) compared to the
background. The 18 best hits among the matched PWMs and the
graphical output of the corresponding consensus sequences are
displayed in figure 3. At position two, five and fourteen, according
to the ranking, we found PWMs representing hypoxia response.
We identified at least one binding site for the human hypoxia-
inducible factor 1 alpha subunit (HIF1A) and the endothelial PAS
domain protein 1 (EPAS1), also known as HIF2A, a transcrip-
tional activator that acts in cell proliferation, cell migration,
hemopoiesis and angiogenesis [32–34], sharing the consensus
sequence 59-ACGTG-39 in ANKRD37, DDIT4, KDM3A,
PPP1R3C, PFKFB4 and VEGFA (figure 4 A). Interestingly,
several PWMs for the forkhead transcription factor superfamily
and one specific for forkhead box O4 (FOXO4), which mediates
HIF1A and VEGF downregulation [35] were also recognized. In
case of ANKRD37, DDIT4 and PPP1R3C binding sites of FOX-
and HIF-family transcription factors overlap (figure 4 B). Apart
Table 1. Significantly regulated genes classified according to their function in SGBS under hypoxia for 16 hours (.2-fold).
Biological process p-value Gene symbol
Glycolysis 0.0006 INSR, ENO2, PFKL, PGK1, ALDOC, HK2, GPI, HK1, PFKP, TPI1
Response to hypoxia 0.0006 EPAS1, VLDLR, PLOD1, VEGFA, HMOX1, ANGPTL4, TFRC, ADM, DDIT4, PLOD2, ALDOC, FLT1, BNIP3, MT3, EGLN3, EGLN1
Regulation of cellular
component movement
0.0038 ABHD2, NF2, MAP2K1, SPHK1, VEGFA, BCAR1, HMOX1, ETS1, KISS1R, INSR, SP100, FLT1, ARAP1, BCL6, TAC1, SCAI,
SCARB1
Response to nutrient levels 0.0073 RARA, VLDLR, AQP3, LIPG, HMOX1, TFRC, ADM, JUN, PTGS2, INSR, SUOX, C14orf104, STC2, LEP, CDKN2D, STC1
Regulation of cell migration 0.0302 ABHD2, INSR, NF2, FLT1, MAP2K1, SPHK1, SCARB1, TAC1, SCAI, VEGFA, BCAR1, HMOX1, KISS1R
Transcription regulator
activity
0.0164 HOXA7, ZNF35, ZNF207, HIVEP3, MXI1, EPAS1, UBP1, CDKN1C, CNOT8, PPARGC1B, KHDRBS1, ETV5, PBX1, ATF7IP,
MEF2A, CEBPA, FOSL2, ETS1, RORA, JUN, E2F7, CAMTA2, HOXA4, SP100, ZNF167, BCL6, RFX5, CREB1, MEIS1, SNAPC5,
CEBPD, SAP30, TGIF1, RARA, TMF1, TCEB3, RFX2, NFIA, WDR77, ATF3, CBL, BCL10, BTG1, ID3, TRIB3, SERTAD2,
SMARCC1, HOXA9, NFIL3, NAB2, DDX5, SCAI, TFDP2, SMAD1, MAFF, RFXAP, FOXQ1, HEY1, KLF7, FUBP1
Gene ontology (GO) tree machine with multiple test adjustment proposed by Benjamini & Hochberg (1995) was used for the enrichment analysis. The adjusted p value
indicates the significance of enrichment.
doi:10.1371/journal.pone.0026465.t001
Figure 1. Venn diagram of the hypoxia-regulated genes in
human adipocytes. Microarray analysis resulted in 10 differentially
regulated genes after 3 hours, 52 differentially regulated genes after
6 hours and 514 differentially regulated genes after 16 hours cultivation
of the cells in a hypoxic environment (1% O2). In the intersection of the
circles the number of genes commonly regulated to the corresponding
time points is indicated. The genes included in this analysis showed at
least a 2-fold change in the expression compared to the control with a
p value ,0.05.
doi:10.1371/journal.pone.0026465.g001
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MDS1 are located within the mentioned promoters. We also
identified PWMs for transcription factor activating enhancer
binding protein 2 (TFAP2A), which is known to activate ADM
expression in monocytic leukemia cells [36], for TFAP4 and for
transcriptional activators of the GATA binding protein family
(figure 3 and 4).
Moreover, reinvestigating the subset of 10 genes upregulated
after 3 h and 6 h of hypoxia (figure 1), BHLHE41, the only gene,
which was excluded by the Venn-Diagramm according to a lack of
upregulation after 16 h, which codes for the Class E basic helix-
loop-helix protein 41 (BHLHE41) mediating sleep length and
apoptosis [37,38], is also known to be activated by HIF-1 [39]. A
functional classification of these ten genes by conducting GO
annotation with the manual curated BKL database supplied by
BIOBASE significantly assigned six of these ten genes (ADM,
DDIT4, KDM3A, PFKFB4, VEGFA and BHLHE41) to response
of hypoxia and oxygen levels with p-values of 1.9 e-8 and 2.0 e-8
respectively and seven of ten to response to stress and chemical
stimulus (table 2).
To prove the validity of the microarray data, the set of the 9
significantly regulated genes after all investigated time periods (3,
6, 16 h) under hypoxia was also determined by real-time PCR.
These validation experiments were equally performed for all time
periods used in the microarray analysis and were assessed by
repeated experiments (figure 5). Overall, the regulation patterns
measured in the real-time PCR experiments reflected the results of
the microarray data, with one exception: In the case of WDR73 of
the validation experiments a significant regulation of gene
expression in the opposite direction was observed compared to
the microarray data. Given the verified transcriptional upregula-
tion of ADM, ANKRD37, DDIT4, KDM3A, PFKFB4,
PPP1R3C, VEGFA and ZNF395 on the one hand and their
clustering in response to hypoxia according to gene ontology, we
were interested in a potentially coordinated expression. Reinves-
tigating the 514 genes upregulated after 16 h, we noticed that
HIF2A is on the one hand a transcription factor, binding to
upregulated genes as diplayed in figure 3 and 4, and, on the other
hand, upregulated itself in SBGS adipocytes after 16h of hypoxia.
According to our binding site analysis, HIF1, HIF2A and TFAP4
together bind all eight genes which were verified by real time PCR
to be upregulated under hypoxia (figure 4) and therefore might be
sufficient to induce their activation.
Discussion
In the present study we identified several hypoxia-regulated
genes, shown for the first time in human adipocytes, by using
Figure 2. Transcriptional induction in response of hypoxia.
Transcriptional induction under hypoxic condition (1% O2) is shown for
the consistently differentially expressed genes after 3, 6 and 16 hours
cultivation of the mature SGBS adipocytes. The fold change values are
shown relative for the expression levels under normoxic conditions.
Only genes, which met a p value of ,0.05 compared to the untreated
control, are shown.
doi:10.1371/journal.pone.0026465.g002
Figure 3. Transcription factors binding sites identified within the promoter regions. The figure displays the sequences of matched
position weight matrices (PWMs) together with the corresponding gene symbols of the transcription factors, which are overrepresented in the
promoters of the 9 upregulated genes. The PWMs are ranked according to their ‘‘Yes/No’’ ratio, which is defined as the ratio of the average number of
putative binding sites per 1000 bp, given for the query (Yes) and the background (No) sets. Overrepresentation is defined as a Yes/No ratio greater
than one. Significance of the representation value is measured by the p-value derived from a binomial distribution. Matched promoters p-value
assesses the statistical significance of the number of promoters in the query set that have at least one predicted site compared to that of promoters
in the background set. Matrix similarity score (mss) and core similarity score (css) are indicated for comparison.
doi:10.1371/journal.pone.0026465.g003
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targets of the hypoxia-sensitive transcription factors HIF1 and
HIF2A and are involved in crucial pathways within the cell and
may contribute to the initiation of mechanisms, which further
promote the development of obesity-related diseases such as type 2
diabetes and the metabolic syndrome.
Our study showed that hypoxia for 16 hours leads to the
significant regulation of over 500 transcripts in human adipocytes
and activates several pathways and biological processes involved in
the supply of energy. The up-regulation of genes involved in
glycolysis to obtain an adequate energy level is used as a survival
strategy for the cell [40]. Furthermore, our data demonstrate that
genes involved in the regulation of cellular component movement
and cell migration are regulated under hypoxic conditions.
Further, a significant enrichment of regulated genes involved in
transcription regulator activity and response to hypoxia was
observed. The regulation of genes involved in these processes is
suggested to lead to adaptive changes, which allow the cell to gain
more energy and lead to the delivery of oxygen [12]. Interestingly,
we could not identify an accumulation of hypoxia-regulated genes
involved in inflammation, although hypoxia in adipose tissue is
suggested to lead to a chronic inflammatory state [41]. Of note,
white adipose tissue consists of different cell types, such as pre-
adipocytes, macrophages, endothelial cells, fibroblasts and leuko-
cytes, which all contribute to the production and release of
cytokines [42,43]. It is also suggested, that the response to hypoxia
differs depending on the cell type and the tissue environment
[44,45]. Therefore, the contribution of adipocytes to the total
amount of secreted factors from adipose tissue in vivo which lead to
a chronic inflammation is not fully understood.
From the large number of hypoxia-regulated transcripts, nine
genes were found to be differentially expressed after all time
periods of hypoxia (3, 6 and 16 hours) investigated in our
microarray study. Our findings in SGBS adipocytes are consistent
with previous reports observed in other cell types. A hypoxia-
induced regulation was described for ADM [46–50], ANKRD37
[51,52], DDIT4 [51,53,54], KDM3A [51,55–57], PFKFB4 [58],
PPP1R3C [59], and ZNF395 [60]. ADM, ANKRD37, DDIT4,
KDM3A, PFKFB4, PPP1R3C and VEGF have also been
described to be direct HIF-targets [50,51,53–56,58,59,61,62].
However, only the hypoxia-induced regulation of VEGF has been
described for adipocytes so far [63,64]. So our results enlarge this
picture as we could demonstrate for the first time that hypoxia
induces also the gene expression of ADM, ANKRD37, DDIT4,
KDM3A, PFKFB4, PPP1R3C and ZNF395 in SGBS adipocytes.
As the SGBS cells, used for this study have been proven in several
human adipocyte biology studies to have characteristics very
similar to adipocytes [21–28] we consider our findings also
relevant for adipocytes in general.
VEGF is essential for the development of the vascular system
and promotes angiogenesis [65] and also ADM has been shown to
induce angiogenesis [66]. Both, the growth of adipose tissue and
hypoxic conditions require the development of the vascular
network. Concentrations of serum VEGF have been described
Figure 4. Binding sites for transcription factors within promoter regions. (A) Tabulated view of all matched matrix sequences for
transcription factors (TF) as displayed in figure 3. Hits for transcription factors which were generated according to different matrices representing the
same transcription factor were summed up. (B) Schematic representation of matched binding sites for transcription factors (arrows) within proximal
promoters of the eight verified hypoxia-induced genes and WDR73. Overlapping binding sites of different matrices which represent the same
transcription factor (family) are indicated as single site in the figure. Binding sites of the unknown factor were omitted.
doi:10.1371/journal.pone.0026465.g004
Table 2. Functional classification of 10 genes upregulated after 3 h of hypoxia by GO annotation.
Biological process/GO ID p-value Gene symbol
Response to hypoxia/GO: 0001666 3.83E-10 ADM, BHLHE41, DDIT4, KDM3A, PFKFB4, VEGFA
Response to oxygen levels/GO:0070482 4.20E-10 ADM, BHLHE41, DDIT4, KDM3A, PFKFB4, VEGFA
Response to stress/GO:0006950 4.21E-05 ADM, BHLHE41, DDIT4, KDM3A, PFKFB4, VEGFA, ZNF395
Response to chemical stimulus/GO:0042221 1.01E-04 ADM, BHLHE41, DDIT4, KDM3A, PFKFB4, VEGFA, ZNF395
The 10 genes upregulated after 3 h of hypoxia were classified according to their biological processes and gene ontology (GO) IDs (www.geneontology.org) by GO
annotation, using manual curated GO groups provided by the Biobase software package Explain.
doi:10.1371/journal.pone.0026465.t002
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reduction led to a decrease in VEGF circulating levels [67]. This
angiogenic factor has also been suggested to be involved in the
development of the comorbidities associated with obesity [68,69].
Furthermore, plasma concentration of the antiadipogenic factor
ADM increases with obesity, the incidence of type 2 diabetes,
cardiovascular diseases and inflammation [70,71]. The expression
of ADM and DDIT4 in adipocytes, which is induced in response
to different situations of cellular stress is in addition to hypoxia also
regulated by insulin [72,73] and in terms of DDIT4, whose
overexpression may participate to the development of insulin
resistance, depends on the transcription factor HIF-1 [73].
Further, also KDM3A has been described as a regulator of
genes involved in energy expenditure and fat storage [74,75].
Therefore, these identified genes may play a crucial role in the
regulation of obesity and the metabolic syndrome.
The remaining hypoxia-regulated genes that were identified are
involved in different cellular functions: protein-protein interaction
and signalling (ANKRD37) [76], glycolysis (PFKFB4) [77],
glucogen accumulation which is suggested as metabolic longterm
adaption to hypoxia (PPP1R3C) [59], and regulation of transcrip-
tion (ZNF395) [78,79]. The function of WD-repeat proteins differs
from signal transduction, regulation of transcription, and apopto-
sis, but the function of WDR73 still remains unknown [80,81].
However, only hypoxia-induced regulation of WDR73 could not
be confirmed by real-time PCR. Compared to fold change
expression of other genes, a small but significant regulation of
WDR73 gene expression in the opposite direction was observed by
real-time PCR compared to the microarray data. This may be due
to different oligonucleotides used for PCR, which are specific for
exon 2 and 4, and those for microarray analysis, detecting
alternative splicing products. However nothing is known about
possible alternative splicing mechanisms of WDR73 RNA.
Interestingly, we did not detect a binding site for hypoxia-
inducible factors 1 and 2 according to our cut off settings. Both
findings argue against a role of WDR73 during hypoxia. However
we do not rule out that there are further hypoxia responsible
elements (HREs) for those factors, as we also did not detect the
HREs described by Garayoa et al. in ADM [50] according to our
settings. Therefore future studies may clarify the regulation and
function of WDR73.
Furthermore we could not only show that most genes,
upregulated by hypoxia, harbour binding sites for HIF1A and
EPAS1, but also that EPAS1 is upregulated after 16h of hypoxia,
indicating a positive feedback mechanism. Looking for general
composite promoter models within these genes we did not detect a
striking conformity. However, we revealed binding sites for
FOXO4 and the forkhead box superfamily within almost every
proximal promoter of the upregulated genes. FOXO transcription
factors mediate anti-angiogenic effects [82] and play a central role
during oxidative stress [83]. In addition, the transcription
regulator FOXO4 is known to downregulate the expression of
EPO, VEGFA and HIF1A [35]. In this context, the direct overlap
of FOX- and HIF-binding sequences within ANKRD37, DDIT4
and PPP1R3C may suggest an interaction or a competition of
these factors for binding to the respective promoter elements. We
suppose that the FOX-family of transcription factors may play an
important role for gene regulation during hypoxia in SGBS
Figure 5. Transcriptional induction according to real-time PCR analysis. Real-time PCR analysis was performed analysing mRNA levels of the
9 genes differentially regulated after 3, 6 and 16 hours treatment under hypoxic conditions (1% O2). Results of 4–6 independent experiments each
performed in triplicate are expressed as mean values 6 SE. Values are depicted relative to the untreated control. *** p,0.001; ** p,0.01; * p,0.05.
doi:10.1371/journal.pone.0026465.g005
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treatment. However, further studies regarding protein expression
patterns in adipocytes will be necessary to test this hypothesis.
Taken together, we demonstrated that hypoxia has an extensive
effect on gene expression of SGBS adipocytes, which responded
with the regulation of genes involved in different crucial biological
processes. In addition, the identified hypoxia-regulated genes have
been in part suggested to be involved in the regulation of obesity,
the incidence of type 2 diabetes, and the metabolic syndrome.
However, adipose tissue in vivo consists also of other cell types
than the investigated adipocytes. Therefore, additional studies
using primary cells e.g. derived from lipoaspirates are needed to be
performed to elucidate the relation of whole adipose tissue hypoxia
and the chronic inflammation observed in obesity. Nevertheless,
we have now established a comprehensive gene expression profile
for these adipocytes under hypoxia.
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